Vascular Diagnostics Articles & Analysis

3 news found

Elucid Presents Data Demonstrating Its AI Software Can Uniquely Quantify Key Drivers of Heart Attack and Stroke from Computed Tomography

BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced today that its founder Andrew Buckler will present findings from two separate studies at the virtual Society of Cardiovascular Computed Tomography (SCCT) 16th Annual Scientific ...

Jul. 16, 2021

ByElucid

Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA)

Computed tomography angiography (CTA) has been increasingly used in the diagnosis of vascular disease and its a modality that offers many potential clinical benefits. ...

May 10, 2021

ByElucid

Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis which could aid in the proper diagnosis of vascular dementia

An innovative eye exam is helping physicians answer these questions with confidence. Optina Diagnostics, a world leader in retinal imaging technology and AI with a vision to change mindsets when it comes to brain health and Dr. ...

Aug. 23, 2019

ByOptina Diagnostics

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you